Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones. Zadro Y, Lusque A, Rey H, Cougoul P, et al. Am J Hematol 2025;100:1670-1674.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zadro Y, Lusque A, Rey H, Cougoul P, et al. Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones. Am J Hematol 2025;100:1670-1674.
PMID: 40626616